Publications

Communications

  Search All Categories
 |  

Invitations [ 4 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
9.107Medical Device Workshop with IndustryV131-Jan-201835 KB
9.110Meeting of CEOs of Complementary Medicines with Board of SAHPRAV109-May-201875 KB
9.91Workshop between Regulator and Industry on Clinical Trial related mattersV102-May-201945 KB
9.98Meeting between CEOs and Chairperson of MCC and RegistrarV102-Aug-201758 KB

Medical Devices [ 3 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
9.105Section 21 authorisation of sale of unregistered medical devicesV129-Dec-201737 KB
9.106Position Statement: Class A Medical DevicesV129-Dec-201741 KB
9.79Medical Device Establishments: Licence RequirementsV120-Sep-201634 KB

Press releases [ 19 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
007/2018Advert for SAHPRA CEOV121-Aug-201839 KB
10.07Press release - withdrawal of rosiglitazoneV111-Jul-20117 KB
10.08Press release - on dextropropoxypheneV124-Nov-2011148 KB
10.09Press release - cough and cold medicinesV101-Jun-201232 KB
10.10Press release - CAMSV113-Jan-201438 KB

Scheduling [ 12 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
9.104Scheduling matters: Rescheduling of atovaquone & proguanilV118-Dec-201738 KB
9.111Rescheduling of IbuprofenV127-Jun-201860 KB
9.112Rescheduling of OrphenadrineV127-Jun-201848 KB
9.118Rescheduling of hyoscine butylbromideV114-Dec-201823 KB
9.61Scheduling of aspirinV211-Mar-201642 KB

Section 21 [ 1 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
9.113Update on submission procedure for all Section 21 authorisationsV231-Oct-201828 KB

[ 57 ]

Type
Doc#
Version
SubVersion
PublishDate
Select
001-2_2019Advert SAHPRA CRO & ARG CommitteeV123-Jan-2019565 KB
9.08Process for handling healthcare professional letters relating to safety and medicine safety alertsV303-Mar-201555 KB
9.100Use of Indian WalnutV102-Oct-201739 KB
9.101Communication with Council and CommitteesV102-Oct-201734 KB
9.102Appointment of Quality and Bioequivalence EvaluatorsV118-Oct-201738 KB
9.103Tissue Engineering ProductsV118-Dec-201738 KB
9.108Meeting between CEOs and Chairperson of SAHPRA BoardV110-Mar-201875 KB
9.114Submission of Pharmacovigilance Correspondence during protest action in Civitas BuildingV125-Sep-201819 KB
9.115Submission of Type B Pharmaceutical Amendments during protest action in Civitas BuildingV125-Sep-201821 KB
9.116Update about the ongoing work of SAHPRA during the interim closure of CivitasV131-Oct-201830 KB
9.117Update on Backlog Clearance ProgramV121-Nov-201827 KB
9.119Medical Devices - Extension of Section 36 exemption: Sections 18A and 18B of Act 101 of 1965V127-Dec-201822 KB
9.120Interim relocation of SAHPRA to CSIRV128-Jan-201928 KB
9.121SAHPRA mourns the passing away of Lesiba Moshiga and his familyV130-Jan-201986 KB
9.122Status of Cannabis cultivation and medicinal useV103-Feb-201938 KB
9.13USRNV130-Jun-2015143 KB
9.17Expert Committees Meeting Dates for 2018V407-Feb-201844 KB
9.22Malaria prophylaxisV109-Mar-2009206 KB
9.25EnoxaparinV103-Aug-200987 KB
9.28Cancellation or withdrawalV101-Sep-200982 KB